Virios Therapeutics: Funding, Investors & Team (Sep 2026)
Virios Therapeutics is a biopharmaceutical company in the clinical stage that is working on developing new antiviral treatments for fibromyalgia and other diseases. The company is focused on improving patient outcomes by addressing the underlying cause of fibromyalgia and related conditions, which may be linked to an overactive immune response triggered by Herpes Simplex Virus-1. Their therapy, IMC-1, aims to suppress the activation and replication of this virus to reduce the burden of viral-mediated diseases. In a Phase 2a trial for fibromyalgia, IMC-1 showed promising results in reducing pain compared to a placebo. The company is planning to move forward with a Phase 2b trial in early 2021, with results expected in early 2022. Founded in 2012, Virios Therapeutics is based in Alpharetta, Georgia.
Virios Therapeutics has raised $6.7M across 2 funding rounds on record, the most recent an undisclosed round of $1.7M announced in May 2024.
That round is below the $4.1M median round size for Apps companies tracked on FundedIQ over the last two years.
Virios Therapeutics Company Profile and Key Stats
Latest funding round on record: May 2024.
Virios Therapeutics Funding Rounds
Virios Therapeutics raised $5.0M in a Post-IPO Equity announced in Sep 2022.
1.7 years later, an undisclosed round of $1.7M was announced in May 2024.
Virios Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Virios Therapeutics Funding Compared to Other Apps Startups
Virios Therapeutics' latest round of $1.7M is below the median round in Apps. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Virios Therapeutics in Apps and Alpharetta
Companies Similar to Virios Therapeutics
K Health is a digital primary care app that uses AI to provide personalized healthcare based on data…
The more intelligent no-code platform, Blaze, makes your company's operations better. We give you the…
Fly.io offers an Application Delivery Network (ADN) expected to assist site proprietors with getting…
WizCommerce is a platform utilizing artificial intelligence to assist B2B wholesalers, distributors, and…
Tickmark dba Taxfyle develops accounting-based applications for iOS and Android platforms as well as newly…
Scaled Cognition offers a model that ensures customer interactions are based on verified answers that adhere…
It is estimated that 45 million individuals are financial caregivers, meaning they are responsible for the…
Trovy is a fintech company that provides applications. analytics, and financial services.
Onyx Odds is a predictions company, specializing in sports predictions.
Valence AI provides real-time emotion AI that adds vocal emotion signals to customer intelligence. By…
Napkin Math is an AI food journal that gamifies nutrition tracking by offering customized guidance to achieve…
OpenWork is a desktop app that enables users to connect their existing skills, MCP servers, and AI agents…
Virios Therapeutics Funding FAQs
What does Virios Therapeutics do?
Virios Therapeutics is a biopharmaceutical company in the clinical stage that is working on developing new antiviral treatments for fibromyalgia and other diseases. The company is focused on improving patient outcomes by addressing the underlying cause of fibromyalgia and related conditions, which may be linked to an overactive immune response triggered by Herpes Simplex Virus-1. Their therapy, IMC-1, aims to suppress the activation and replication of this virus to reduce the burden of viral-mediated diseases. In a Phase 2a trial for fibromyalgia, IMC-1 showed promising results in reducing pain compared to a placebo. The company is planning to move forward with a Phase 2b trial in early 2021, with results expected in early 2022. Founded in 2012, Virios Therapeutics is based in Alpharetta, Georgia.
How much funding has Virios Therapeutics raised?
Virios Therapeutics has raised $6.7M across 2 rounds on record. The most recent is an undisclosed round of $1.7M announced in May 2024.
When did Virios Therapeutics last raise funding?
Virios Therapeutics' most recent funding round on record is an undisclosed round of $1.7M, announced in May 2024.
Who founded Virios Therapeutics?
FundedIQ lists William Pridgen (Founder) at Virios Therapeutics.
Who is the CEO of Virios Therapeutics?
Greg Duncan is listed as CEO at Virios Therapeutics.
Where is Virios Therapeutics headquartered?
Virios Therapeutics is based in Alpharetta, Georgia, United States.
How many employees does Virios Therapeutics have?
Virios Therapeutics is in the 51-100 employee band.
How does Virios Therapeutics' funding compare to other Apps startups?
Virios Therapeutics' latest round of $1.7M is below the $4.1M median round size for Apps companies on FundedIQ across 2,426 tracked companies over the last two years.
About FundedIQ's Virios Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Virios Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.